Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewGSK 319347A is a potent and selective IKKε inhibitor (pIC50 = 7.4). Exhibits >100-fold selectivity for IKKε over IKKα IKKβ, and a range of other kinases.
GSK 319347A is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.
M. Wt | 469.53 |
Formula | C22H19N3O5S2 |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 862812-98-4 |
PubChem ID | 11626927 |
InChI Key | LDTAHRLHGHFHKP-UHFFFAOYSA-N |
Smiles | CS(C1=CC=CC=C1COC2=C(C#N)SC(N3C4=CC(OC)=C(OC)C=C4N=C3)=C2)(=O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 46.95 | 100 |
The following data is based on the product molecular weight 469.53. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.13 mL | 10.65 mL | 21.3 mL |
5 mM | 0.43 mL | 2.13 mL | 4.26 mL |
10 mM | 0.21 mL | 1.06 mL | 2.13 mL |
50 mM | 0.04 mL | 0.21 mL | 0.43 mL |
References are publications that support the biological activity of the product.
Bamborough et al (2006) 5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-ε kinase. Bioorg.Med.Chem.Lett. 16 6236 PMID: 16997559
If you know of a relevant reference for GSK 319347A, please let us know.
Keywords: GSK 319347A, GSK 319347A supplier, GSK319347A, potent, selective, IKKepsilon, ε, inhibitor, inhibits, IkB, Kinase, NF-kB/IkB, 5672, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for GSK 319347A include:
Mina J et al (2022) The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings. Mol Oncol 16 130-147 PMID: 34058066
Do you know of a great paper that uses GSK 319347A from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review GSK 319347A and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image